Protein A Resin Market revenue is set to exceed USD 1 billion by 2026, according to a new research report by Global Market Insights Inc.
Growing adoption of chromatography for protein purification and increasing focus of market players on new drug development for the treatment of various chronic and infectious diseases will drive protein A resin market growth. Moreover, rising demand for therapeutic antibodies across the globe will escalate the market demand over the forecast period.
Increasing number of pharmaceutical and biotechnology industry will offer lucrative market growth opportunity
Increasing investment in R&D activities by the market players for development of monoclonal antibodies is one of the key factors driving protein A resins industry growth. For instance, in January 2017, Kaneka announced the launch of New Protein A Chromatography Resin with enhanced binding capacity for the purification of antibody drugs. Growing demand of chromatography technique for biological substance identification and purification globally will impel the demand for protein A resins in the market. Moreover, increasing emphasis on development of novel therapies will foster adoption of protein A resins. However, high cost related to protein A resins may impede the industry growth.
Get more details on this report - Request Free Sample PDF
Growing incidence of autoimmune and rare diseases will favor protein A resin market expansion
Immunoprecipitation application accounted for more than USD 133 million revenue in 2019. Immunoprecipitation is used to precipitate protein antigen using an antibody out of the solution. It is generally used at small scale to fortify downstream analysis. Moreover, increase in usage of immunoprecipitation will in turn favor the demand for protein A resins, thereby impacting the segment size over the forthcoming years.
Browse key industry insights spread across 131 pages with 251 market data tables & 14 figures & charts from the report, “Protein A Resins Market Size By Application (Immunoprecipitation, Antibody Purification), By Product (Natural Protein A, Recombinant Protein A), By Matrix Type (Agarose-based Matrix, Glass or Silica Gel-based Matrix, Organic Polymer-based Matrix), By End-use (Biopharmaceutical Companies, Clinical Research Laboratories, Academic Research Institutes, Contract Research Organizations), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2020 - 2026” in detail along with the table of contents:
Rising popularity of protein A resins in chromatography will boost the market growth
According to the report, the natural protein A resin market demand is projected to witness over 8.8% CAGR through 2026. Owing to high capacity of antibody purification by natural protein A resins, the segment will witness lucrative market growth. However, pertaining to its less benefits over recombinant protein A, market may foresee gradual growth in the forthcoming years.
Growing prospective of glass or silica gel-based matrix in biomedical industry will boost the segmental growth
Protein A resin market by matrix type includes agarose-based matrix, glass or silica gel-based matrix and organic polymer-based matrix. Glass or silica gel-based matrix segment is expected to expand at 8.9% CAGR during the forecast period. This matrix offers benefits such as chemical and high thermal stability, neutral pH, less toxicity, high surface area and easy availability on commercial level, thus creating lucrative growth opportunities for the market in the forecasted time period. Moreover, expansion of biopharmaceutical and biomedical industry will offer positive growth potential in the forthcoming years.
Effective care and various services offered by clinical research laboratories will offer lucrative market growth
Clinical research laboratories end user segment is poised to exceed USD 32 million by 2026, says the analysis. High market growth is attributed to increasing incidence of chronic disorders, expanding testing services in clinics and enhanced productivity. Robust research and development activities and ongoing large number of clinical trials on mAb will further spur the market size of protein A resins.
Europe to progress rapidly due to increasing R&D activities and improving treatment methods
Europe protein A resin market held more than 21% revenue share in 2019 and will robust growth over the analysis timeframe. Regional growth is attributed to increasing demand for therapeutic antibodies, growing use of chromatography in protein engineering and increasing number of biopharmaceutical companies. Moreover, strong foothold of key industry players focusing on new drug development will further accelerate the market growth in the forthcoming years.
Adoption of protein A resins by major market players in protein engineering will pave way for industry growth
Some of the notable players operating in the protein A resin market share include Bio-Rad Laboratories, Inc., GE Healthcare, Purolite Life Sciences, Expedeon Ltd and Repligen among others. These market leaders primarily focus on strategic alliances including acquisitions & mergers and new product launches to broaden their product portfolio and capitalize on market opportunities.
Explore More on Related Topics: